veltassa
vifor fresenius medical care renal pharma france - patiromer szorbitex kalcium - hiperkalémiára - gyógyszerek kezelés, hyperkalaemia, hyperphosphatemia - a veltassa felnőttek hyperkalaemia kezelésére javallt.
zildalis 3,6 mg implantátum előretöltött fecskendőben
teva gyógyszergyár zrt. - goserelin -
ducressa 1 mg/ml + 5 mg/ml oldatos szemcsepp
santen oy - levofloxacin; dexamethasone -
memantin stada 10 mg filmtabletta
stada arzneimittel ag - memantin -
memantine grindeks 10 mg filmtabletta
as grindeks - memantin-hidroklorid -
slinda 4 mg filmtabletta
exeltis kft. - drospirenone -
infilea 0,5 mg/g krém
egis gyógyszergyár zrt. - clobetasol propionate -
eladynos
theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalcium homeosztázis - a csontritkulás kezelése a posztmenopauzás nőknél a törések kockázatának fokozódásával.
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatidot - osteoporosis; osteoporosis, postmenopausal - kalcium homeosztázis - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teriparatidot - osteoporosis; osteoporosis, postmenopausal - kalcium homeosztázis - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.